PTPRC and neoplasm: Our results show that CD45+, CD4+, and CD8+ T cells were increased in tumor tissues after cisplatin treatment, and the proportions of CD45+ and CD8+ T cells were significantly increased in the shIDH3α+CDDP group (Figure 6G,H).